4.8 Article

GRK6 deficiency in mice causes autoimmune disease due to impaired apoptotic cell clearance

期刊

NATURE COMMUNICATIONS
卷 4, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms2540

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan
  2. Takeda Science Foundation
  3. Uehara Memorial Foundation
  4. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  5. Institute for Enzyme Research, the University of Tokushima
  6. Funding Program for Next Generation World-Leading Researchers (NEXT Program)
  7. Grants-in-Aid for Scientific Research [23659042, 25293018, 24113717, 23390087, 23659043, 22590083, 23570231, 25670031, 23659192, 20117013, 23659626] Funding Source: KAKEN

向作者/读者索取更多资源

Efficient engulfment of apoptotic cells is critical for maintaining tissue homoeostasis. When phagocytes recognize 'eat me' signals presented on the surface of apoptotic cells, this subsequently induces cytoskeletal rearrangement of phagocytes for the engulfment through Rac1 activation. However, the intracellular signalling cascades that result in Rac1 activation remain largely unknown. Here we show that G-protein-coupled receptor kinase 6 (GRK6) is involved in apoptotic cell clearance. GRK6 cooperates with GIT1 to activate Rac1, which promotes apoptotic engulfment independently from the two known DOCK180/ELMO/Rac1 and GULP1/Rac1 engulfment pathways. As a consequence, GRK6-deficient mice develop an autoimmune disease. GRK6-deficient mice also have increased iron stores in splenic red pulp in which F4/80(+) macrophages are responsible for senescent red blood cell clearance. Our results reveal previously unrecognized roles for GRK6 in regulating apoptotic engulfment and its fundamental importance in immune and iron homoeostasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Physiology

TRPC3 participates in angiotensin II type 1 receptor-dependent stress-induced slow increase in intracellular Ca2+ concentration in mouse cardiomyocytes

Yohei Yamaguchi, Gentaro Iribe, Toshiyuki Kaneko, Ken Takahashi, Takuro Numaga-Tomita, Motohiro Nishida, Lutz Birnbaumer, Keiji Naruse

JOURNAL OF PHYSIOLOGICAL SCIENCES (2018)

Article Biochemistry & Molecular Biology

2-Oxo-histidine-containing dipeptides are functional oxidation products

Hideshi Ihara, Yuki Kakihana, Akane Yamakage, Kenji Kai, Takahiro Shibata, Motohiro Nishida, Ken-ichi Yamada, Koji Uchida

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Physiology

TRPC channels in exercise-mimetic therapy

Takuro Numaga-Tomita, Sayaka Oda, Kazuhiro Nishiyama, Tomohiro Tanaka, Akiyuki Nishimura, Motohiro Nishida

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2019)

Review Physiology

Mitochondrial dynamics in exercise physiology

Tomohiro Tanaka, Akiyuki Nishimura, Kazuhiro Nishiyama, Takumi Goto, Takuro Numaga-Tomita, Motohiro Nishida

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2020)

Article Biochemistry & Molecular Biology

TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN

Takuro Numaga-Tomita, Tsukasa Shimauchi, Sayaka Oda, Tomohiro Tanaka, Kazuhiro Nishiyama, Akiyuki Nishimura, Lutz Birnbaumer, Yasuo Mori, Motohiro Nishida

FASEB JOURNAL (2019)

Article Biochemistry & Molecular Biology

Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic overload

Akiyuki Nishimura, Kakeru Shimoda, Tomohiro Tanaka, Takashi Toyama, Kazuhiro Nishiyama, Yasuhiro Shinkai, Takuro Numaga-Tomita, Daiju Yamazaki, Yasunari Kanda, Takaaki Akaike, Yoshito Kumagai, Motohiro Nishida

SCIENCE SIGNALING (2019)

Article Multidisciplinary Sciences

TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy

Suhaini Binti Sudi, Tomohiro Tanaka, Sayaka Oda, Kazuhiro Nishiyama, Akiyuki Nishimura, Caroline Sunggip, Supachoke Mangmool, Takuro Numaga-Tomita, Motohiro Nishida

SCIENTIFIC REPORTS (2019)

Review Cell Biology

TRPC Channels in Cardiac Plasticity

Takuro Numaga-Tomita, Motohiro Nishida

Article Multidisciplinary Sciences

Structural library and visualization of endogenously oxidized phosphatidylcholines using mass spectrometry-based techniques

Yuta Matsuoka, Masatomo Takahashi, Yuki Sugiura, Yoshihiro Izumi, Kazuhiro Nishiyama, Motohiro Nishida, Makoto Suematsu, Takeshi Bamba, Ken-ichi Yamada

Summary: This study constructed a library of 465 oxPCs using mass spectrometry and found that doubly oxygenated polyunsaturated fatty acid (PUFA)-PCs are generated in the early phase of acetaminophen-induced acute liver failure.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer

Naoya Hirata, Shigeru Yamada, Shota Yanagida, Atsushi Ono, Yukuto Yasuhiko, Motohiro Nishida, Yasunari Kanda

Summary: This study identified the highly expressed LPA receptor 3 in ALDH-positive TNBC cells and elucidated the regulatory role of the LPA-TRPC3 signaling axis in BCSCs. The findings provide important insights into potential therapeutic targets for TNBC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Long-Acting Thioredoxin Ameliorates Doxorubicin-Induced Cardiomyopathy via Its Anti-Oxidative and Anti-Inflammatory Action

Ryota Murata, Hiroshi Watanabe, Hiroto Nosaki, Kento Nishida, Hitoshi Maeda, Motohiro Nishida, Toru Maruyama

Summary: In this study, a long-acting Thioredoxin (Trx) was prepared by fusing human Trx with human serum albumin (HSA) and its efficacy in treating drug-induced heart failure was evaluated. The results showed that HSA-Trx administration suppressed the adverse effects of drug-induced cardiomyopathy, including heart weight decrease, myocardial fibrosis increase, and markers for myocardial damage. HSA-Trx also inhibited oxidative stress and inflammation, as well as the expression of myocardial atrophy factors. The findings suggest that HSA-Trx can improve the pathological condition associated with doxorubicin-induced cardiomyopathy.

PHARMACEUTICS (2022)

Review Pharmacology & Pharmacy

Drug repurposing for the treatment of COVID-19

Yuri Kato, Kazuhiro Nishiyama, Akiyuki Nishimura, Takamasa Noda, Kaori Okabe, Takahiro Kusakabe, Yasunari Kanda, Motohiro Nishida

Summary: This article discusses the global research efforts and outcomes of drug repurposing for the treatment of COVID-19, and introduces a new protein-protein interaction that is common to COVID-19 aggravation and heart failure.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)

Article Cell Biology

A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia

Tsukasa Shimauchi, Takuro Numaga-Tomita, Yuri Kato, Hiroyuki Morimoto, Kosuke Sakata, Ryosuke Matsukane, Akiyuki Nishimura, Kazuhiro Nishiyama, Atsushi Shibuta, Yutoku Horiuchi, Hitoshi Kurose, Sang Geon Kim, Yasuteru Urano, Takashi Ohshima, Motohiro Nishida

Summary: Inhibition of TRPC6 channel activity in vascular smooth muscle cells promotes blood flow recovery in peripheral artery disease. The drug 1-BP can inhibit this channel activity, leading to improved peripheral circulation and skeletal muscle mass. Additionally, 1-BP can increase vascular nitric oxide bioavailability and enhance blood flow recovery in patients with endothelial dysfunction.
Article Biochemistry & Molecular Biology

Knockout of Purinergic P2Y6 Receptor Fails to Improve Liver Injury and Inflammation in Non-Alcoholic Steatohepatitis

Kazuhiro Nishiyama, Kohei Ariyoshi, Akiyuki Nishimura, Yuri Kato, Xinya Mi, Hitoshi Kurose, Sang Geon Kim, Motohiro Nishida

Summary: Nonalcoholic steatohepatitis (NASH) is a disease characterized by inflammation and fibrosis that progresses from nonalcoholic fatty liver (NAFL). The study reveals that the P2Y(6) receptor (P2Y(6)R) is upregulated in NASH liver and positively correlates with the expression of CCL2 and Coll1a1. However, the functional deficiency of P2Y(6)R does not seem to affect the progression of liver injury.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biology

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction

Akiko Ogawa, Seiya Ohira, Yuri Kato, Tatsuya Ikuta, Shota Yanagida, Xinya Mi, Yukina Ishii, Yasunari Kanda, Motohiro Nishida, Asuka Inoue, Fan-Yan Wei

Summary: The antiviral drug remdesivir used for COVID-19 treatment has been found to have cardiovascular side effects, but the underlying mechanism was unclear. Through screening and modeling, researchers discovered that remdesivir acts as a selective, partial agonist for the UTS2R receptor, leading to cardiac malfunctions. Antagonizing UTS2R signaling was found to effectively attenuate the cardiac effects of remdesivir.

COMMUNICATIONS BIOLOGY (2023)

暂无数据